Incyte (INCY) Net Margin (2010 - 2026)
Incyte posted quarterly Net Margin of 23.83% for Q1 2026, up 881.0% year-on-year from 2.43% in Q1 2025, and up 20.0% on a QoQ basis from 19.86% in Q4 2025.
Incyte (INCY) has 17 years of Net Margin data on file, last reported at 23.83% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 881.0% year-over-year to 23.83%; the trailing twelve-month figure through Mar 2026 stood at 26.71% (up 2623.0% YoY), and the FY2025 full-year result was 25.03%, up 2426.0% from the prior year.
- Net Margin for Q1 2026 stood at 23.83%, up from 19.86% in the prior quarter.
- Across five years, Net Margin topped out at 33.32% in Q2 2025 and bottomed at 42.6% in Q2 2024.
- The 5-year median for Net Margin is 17.71% (2022), against an average of 13.43%.
- The widest annual swing landed in 2024, when Net Margin slumped 6392 bps; it then soared 7591 bps in 2025.
- A 5-year view of Net Margin shows it stood at 3.07% in 2022, then soared by 546 bps to 19.84% in 2023, then retreated by 14 bps to 17.07% in 2024, then gained by 16 bps to 19.86% in 2025, then rose by 20 bps to 23.83% in 2026.
- The last three Net Margin figures came in at 23.83% (Q1 2026), 19.86% (Q4 2025), and 31.05% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 17.65% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 23.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.83% |
| Dec 31, 2025 | 19.86% |
| Sep 30, 2025 | 31.05% |
| Jun 30, 2025 | 33.32% |
| Mar 31, 2025 | 15.03% |
| Dec 31, 2024 | 17.07% |
| Sep 30, 2024 | 9.36% |
| Jun 30, 2024 | -42.60% |
| Mar 31, 2024 | 19.25% |
| Dec 31, 2023 | 19.84% |
| Sep 30, 2023 | 18.64% |
| Jun 30, 2023 | 21.32% |
| Mar 31, 2023 | 2.68% |
| Dec 31, 2022 | 3.07% |
| Sep 30, 2022 | 13.70% |
| Jun 30, 2022 | 17.71% |
| Mar 31, 2022 | 5.18% |
| Dec 31, 2021 | 65.35% |
| Sep 30, 2021 | 22.35% |
| Jun 30, 2021 | 21.18% |
| Mar 31, 2021 | 8.85% |
| Dec 31, 2020 | 18.98% |
| Sep 30, 2020 | -2.45% |
| Jun 30, 2020 | 42.19% |
| Mar 31, 2020 | -126.76% |
| Dec 31, 2019 | 19.16% |
| Sep 30, 2019 | 23.26% |
| Jun 30, 2019 | 19.87% |
| Mar 31, 2019 | 20.55% |
| Dec 31, 2018 | 13.07% |
| Sep 30, 2018 | 6.49% |
| Jun 30, 2018 | 10.05% |
| Mar 31, 2018 | -10.76% |
| Dec 31, 2017 | -33.69% |
| Sep 30, 2017 | 9.45% |
| Jun 30, 2017 | -3.82% |
| Mar 31, 2017 | -48.71% |
| Dec 31, 2016 | 2.72% |
| Sep 30, 2016 | 13.69% |
| Jun 30, 2016 | 13.98% |
| Mar 31, 2016 | 9.13% |
| Dec 31, 2015 | 22.62% |
| Sep 30, 2015 | -21.10% |
| Jun 30, 2015 | 5.70% |
| Mar 31, 2015 | -11.53% |
| Dec 31, 2014 | -29.80% |
| Sep 30, 2014 | 29.92% |
| Jun 30, 2014 | -37.03% |
| Mar 31, 2014 | -37.82% |
| Dec 31, 2013 | -44.16% |
| Sep 30, 2013 | -25.89% |
| Jun 30, 2013 | -2.53% |
| Mar 31, 2013 | -22.05% |
| Dec 31, 2012 | 16.50% |
| Sep 30, 2012 | -35.89% |
| Jun 30, 2012 | 4.66% |
| Mar 31, 2012 | -125.56% |
| Dec 31, 2011 | -190.66% |
| Sep 30, 2011 | -316.28% |
| Jun 30, 2011 | -308.55% |
| Mar 31, 2011 | -82.92% |
| Dec 31, 2010 | 37.90% |
| Sep 30, 2010 | -187.89% |
| Jun 30, 2010 | 6.11% |
| Mar 31, 2010 | -206.67% |